Etiome Unveils AI Platform for Preemptive Healthcare
Flagship Pioneering has launched Etiome, a company dedicated to advancing preemptive healthcare through its AI-powered Temporal Biodynamics platform. Announced in a press release, Etiome aims to redefine disease detection and intervention by identifying and addressing diseases at their earliest stages.
The Temporal Biodynamics platform is designed to forecast disease progression and develop Biostaged Medicines that can halt or reverse diseases before they become debilitating. With an initial investment of $50 million from Flagship Pioneering, Etiome plans to focus on serious and progressive diseases such as metabolic, neurodegenerative, pre-cancerous, and autoimmune conditions.
Etiome's approach combines multimodal data and AI to gain insights into disease biology, allowing for the development of targeted interventions. This initiative marks a significant shift towards preemptive medicine, aiming to improve health outcomes and reduce healthcare costs by addressing diseases before they cause significant harm.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ProFound Gets Gates Foundation Investment for AI Maternal Health Research
Atman Health Wins ARPA-H Award to Build Heart Failure AI
UT Medical and TransformativeMed Build Agentic AI Discharge Planning Tool
World Class Health Introduces AI Specialty Clinic
Jetstream Venture Fund Invests in ImageAiD and Moonrise Medical
Daily AI Brief: the AI news that matters, in your inbox.